Statement Of Cash Flows [Abstract]

Captor Therapeutics S.A. - Filing #6064395

Concept	2024-01-01 to 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Income taxes paid (refund), classified as operating activities	0 PLN	—	0 PLN	—	—
Cash flows from (used in) operating activities	31 878 PLN	—	52 204 PLN	—	—
Cash flows from (used in) investing activities [abstract]
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities	6 000 PLN	—	70 117 PLN	—	—
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities	5 928 PLN	—	50 451 PLN	—	—
Cash advances and loans made to other parties, classified as investing activities	0 PLN	—	0 PLN	—	—
Cash receipts from repayment of advances and loans made to other parties, classified as investing activities	0 PLN	—	0 PLN	—	—
Interest received, classified as investing activities	625,000 PLN	—	3 270 PLN	—	—
Cash flows from (used in) investing activities	273,000 PLN	—	19 931 PLN	—	—
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares	3,000 PLN	—	40 008 PLN	—	—
Repayments of borrowings, classified as financing activities	0 PLN	—	0 PLN	—	—
Payments of lease liabilities, classified as financing activities	4 355 PLN	—	1 641 PLN	—	—
Interest paid, classified as financing activities	385,000 PLN	—	318,000 PLN	—	—
Cash flows from (used in) financing activities	4 842 PLN	—	36 941 PLN	—	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	36 447 PLN	—	4 668 PLN	—	—
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes	36 447 PLN	—	4 668 PLN	—	—
Cash and cash equivalents	—	39 257 PLN	—	75 704 PLN	71 036 PLN